STAGE IIIA BLADDER CANCER AJCC V8
Clinical trials for STAGE IIIA BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy boost for bladder cancer: could adding atezolizumab to standard treatment be a Game-Changer?
Disease control OngoingThis phase 3 trial tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with muscle-invasive bladder cancer live longer without their cancer returning or needing bladder removal. About 475 adults with localized disease are participating…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New combo aims to tame immunotherapy side effects in advanced cancers
Disease control OngoingThis study tests whether adding tocilizumab to standard immunotherapy (ipilimumab and nivolumab) can reduce severe side effects in people with advanced melanoma, lung cancer, or bladder cancer. About 35 participants will receive the combination to see if it is safer and still eff…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Can a simple gene test predict who will beat bladder cancer?
Knowledge-focused OngoingThis study looks at whether certain genetic changes in tumors can help doctors know which patients with advanced bladder cancer will benefit from the immunotherapy drug nivolumab. Researchers are testing tumor samples for specific gene mutations and a protein called CXCL13. The g…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC
-
Bladder cancer survivors: new study tracks life after treatment
Knowledge-focused OngoingThis study follows 204 people with early to mid-stage bladder cancer to see how their treatment (surgery or radiation) affects their daily life. Participants fill out surveys about physical function, pain, fatigue, mood, and social activities. The goal is to understand which trea…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC